SmPC or Summary of Product Characteristics is a legal document which is a part of the marketing authorization of every medicine. The document acts as a basis of information on the use of medicines for healthcare professionals. The information included in the SmPC is updated regularly as per the emergence of the latest information. SmPC contains more information than a Package Leaflet. The SmPC information can be found through the following sources:
Websites of Health Authorities; such as the European Medicines Agency (EMA)
What consists of an SmPC?
Information related to the medicine usage
Qualitative and quantitative information on medicinesâ€™ benefits and risks
Individual care information
Structure of an SmPC
The structure of the SmPC is defined by the European pharmaceutical legislation. The information included in the SmPC should be product specific and can be cross-referenced to avoid any redundancy. It should be documented in a clear language and should not lead to any ambiguity. The SmPC is divided into 6 major sections:
Name of the product
Clinical particulars â€“ Includes therapeutic indications, recommendation for dosages and safety information
Pharmacological properties â€“ Takes into account the therapeutic indications of the clinical elements and their potential adverse drug reactions
Pharmaceutical particulars â€“ Includes Regulatory information related to the drug
As per the EMA structure of an SmPC can be depicted as:
Structure of an SmPC
What Information is Excluded from an SmPC?
Information available in the public assessment reports (scientific development details)
Unapproved indication information
Issues which lack data
General advice on pharmacological conditions
Maintaining an SmPC is important for the life cycle of any medicine as it is a part of its marketing authorization. Therefore, authoring a compliant SmPC is highly recommended. Are you looking for expert Regulatory assistance to develop an SmPC? Reach out to Freyr @ email@example.com.
About the Author:
This article talks about the Digitalization and automation of Pharmaceutical Artwork and how it helps to minimize artwork errors, bring products faster to market and stay compliant with the Regulatory requirements.